http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103479626-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18781a62c0b82994ab92df6c65b77fbe |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate | 2013-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92afc6c18f44665396dea1c2a61b83fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cbcdee83455a25f8ec2a1207904917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16151cc5ef970a387c18a082a5cd674a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7e1f939137e62f0bc8d91b9b6d2217 |
| publicationDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103479626-B |
| titleOfInvention | Application of Fluevirosines A in preparation of Alzheimer's disease treatment medicines |
| abstract | The invention discloses a new use of Fluevirosines A having acetylcholinesterase activity inhibition and nerve cell protection effects in the preparation of Alzheimer's disease treatment medicines as a multi-target compound. The skeleton type of the Fluevirosines A is a brand new skeleton type, and the Fluevirosines A has a high acetylcholinesterase inhibition activity, has protruding substantive characteristics, and can substantially improve the Alzheimer's disease prevention and treatment. |
| priorityDate | 2013-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.